Trophos' management team comes from both biotech and the pharmaceutical industry:
Damian Marron, Ph.D., CEO, has over 20 years biotechnology and pharmaceutical industry experience. Prior to joining Trophos he was Executive Vice President, Corporate Development at Nicox SA.
Rebecca Pruss, Ph.D., CSO, has over 15 years of experience in R&D with major pharmaceutical companies. Prior to joining Trophos she was the head of Exploratory Research at Sanofi-Synthelabo, now Sanofi-Aventis.
Jean-Louis Abitbol, M.D., CMO, has over 20 years' experience directing clinical trials through Phase 3 and product registration with Parke Davis, Pfizer and Pierre Fabre.
Christine Placet, CFO, has 17 years' experience in various areas of finance from Ernst & Young and a number of growing companies and start-ups.
Brigitte Chamayou-Anglade, Pharmacist., CRA, was previously responsible for regulatory affairs with Laboratoires Chauvin.
Patrick Berna, Ph.D., CDO, has over 10 years experience in R&D project management with Jouveinal, Parke-Davis, Pfizer and most recently Boehringer-Ingelheim.
Stephen Harris, Ph.D., CBDO, has over 18 years experience in pharmaceutical R&D with Glaxo, most recently as a Director of Business Development at GSK.